Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB26FUJMD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,786
Award facts
- Contract value 100% obligated
- $3,785.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,785.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nucala 100 mg/mL auto-injector medication. The delivery order, issued on November 12, 2025, carries an ultimate completion date of November 13, 2025, with no set-aside designation applied. DMS Pharmaceutical Group is performing the work at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036. The PPV-G GEN V contract authorizes the Defense Logistics Agency to issue delivery orders for a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense military healthcare operations globally. DMS Pharmaceutical Group has demonstrated substantial federal contracting performance through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, supplying specialized pharmaceuticals including biologics, oncology treatments, vaccines, and emergency medications to federal agencies.
Quick answers
Who was awarded contract SPE2DB26FUJMD?
SPE2DB26FUJMD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FUJMD worth?
The government has obligated $3,786 on SPE2DB26FUJMD.
Is contract SPE2DB26FUJMD an order under another contract?
Yes. SPE2DB26FUJMD is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB26FUJMD competed?
The extent of competition for SPE2DB26FUJMD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award